SBC Medical Group (NASDAQ:SBC) Shares Down 6.1% - Should You Sell?

Key Points

• SBC Medical Group shares fell 6.1% to approximately $5.35 in mid-day trading, with volume running 30% below the average.
• Analysts remain generally optimistic, with two Buy ratings and one Hold rating producing a “Moderate Buy” consensus and an average price target of $8.50.
• The company exceeded quarterly revenue expectations with $49.19 million but missed EPS estimates, reporting $0.10 versus the projected $0.12; institutional investors own 60.82% of the stock.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) shares dropped 6.1% during mid-day trading on Friday. The stock traded as low as $5.40 and last traded at $5.3450. Approximately 82,177 shares were traded during trading, a decline of 30% from the average daily volume of 117,536 shares. The stock had previously closed at $5.69.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on SBC shares. BTIG Research reiterated a "buy" rating and issued a $8.00 price target on shares of SBC Medical Group in a report on Thursday, August 13th. Weiss Ratings upgraded shares of SBC Medical Group from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, October 9th. Finally, Wall Street Zen raised SBC Medical Group from a "buy" rating to a "strong-buy" rating in a research report on Monday, October 5th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, SBC Medical Group currently has an average rating of "Moderate Buy" and a consensus price target of $8.50.

SBC Medical Group Stock Performance

The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31. The company's fifty day simple moving average is $4.67 and its two-hundred day simple moving average is $3.76. The stock has a market capitalization of $546.24 million, a P/E ratio of 11.31, a PEG ratio of 2.49 and a beta of 0.56.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. The business had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. As a group, equities analysts forecast that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in SBC Medical Group during the second quarter valued at $2,846,000. Citadel Advisors LLC purchased a new stake in SBC Medical Group during the 2nd quarter valued at approximately $446,000. Segall Bryant & Hamill LLC bought a new stake in shares of SBC Medical Group in the first quarter worth about $340,000. State Street Corp lifted its stake in shares of SBC Medical Group by 59.7% in the 2nd quarter. State Street Corp now owns 49,239 shares of the company's stock valued at $152,000 after purchasing an additional 18,400 shares during the last quarter. Finally, Williams & Novak Wealth Management LLC lifted its position in shares of SBC Medical Group by 40.9% during the third quarter. Williams & Novak Wealth Management LLC now owns 26,330 shares of the company's stock worth $130,000 after purchasing an additional 7,644 shares during the last quarter. Hedge funds and other institutional investors own 60.82% of the company's stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services.

The company's services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.